Skip to main content
Fig. 6 | Cancer & Metabolism

Fig. 6

From: Systemic inflammation and insulin resistance-related indicator predicts poor outcome in patients with cancer cachexia

Fig. 6

The subgroup analysis of the CTI in the total cohort of patients with cancer cachexia. Adjusted for age, sex, BMI, tumor stage, tumor type, KPS, surgery, chemotherapy, radiotherapy, smoking status, alcohol consumption, KPS, EORTC QLQ-C30, ECOG PS, PGSGA, diabetes, hypertension, coronary heart disease, and TSF. Notes: CTI, C-reactive protein-triglyceride glucose index; BMI: body mass index; KPS, karnofsky performance status; EORTC QLQ-C30, The European Organization for Research and Treatment of Cancer (EORTC), Quality of Life Questionnaire-Core 30 (QLQ-C30); ECOG PS: eastern cooperative oncology group performance status; PGSGA, Patient Generated Subjective Global Assessment; TSF, triceps skinfold thickness

Back to article page